Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication Keytruda…
JHVEPhoto/iStock Editorial via Getty ImagesThe FDA has reportedly approved an injectable formulation of Bristol-Myers Squibb’s (NYSE:BMY) oncology drug Opdivo. Previously,…
